PATENT CLAIM ANALYSIS

Application Number: 16179219
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["424", "141100"]

Abstract:
The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.

Claim (Index 150):
The stable formulation of  claim 137 , wherein the anti-OSMR antibody has a pI ranging from 6.5 to 8.5.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 98.0
- Lexical Diversity: 1.15556
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15950974', '12718783', '15416289', '13850849', '14114835']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7471480017303398
- 35 USC 102 Novelty (BERT): 0.5835674378632214
- Combined Prediction Score: 0.730789945343628
- Mean Citation Score: 347.0664480000001
- Max Citation Score: 523.0726
- Similarity Product: 403.01737019402987

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test